GOLDMAN SACHS GROUP INC

Position in WHWK — Whitehawk Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Position in WHWK

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$196,346

-$28,888 QoQ

Shares Held

56,912

-63.1% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. WHWK ranks #324 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,417,875	$1,079,677,898
2	REGN	Regeneron Pharmaceuticals, Inc.	1,300,558	$1,004,863,129
3	MRNA	Moderna, Inc.	6,603,697	$335,467,805
4	ROIV	Roivant Sciences Ltd.	11,111,591	$307,791,069
5	PRAX	Praxis Precision Medicines, Inc.	710,734	$228,991,385
6	INCY	Incyte Corp	2,351,221	$221,296,919
7	RVMD	Revolution Medicines, Inc.	2,185,500	$212,539,874
8	RYTM	Rhythm Pharmaceuticals, Inc.	1,965,432	$170,933,620

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$196,346	56,912	-63.1%	Shares	Defined	2026-05-15
2024-06-30	$225,234	154,270	+211.2%	Shares	Defined	2024-08-13
2024-03-31	$116,014	49,579	+96.6%	Shares	Defined	2024-05-15
2023-06-30	$172,470	25,215	+2.1%	Shares	Defined	2024-05-14
2023-03-31	$178,798	24,696	-9.7%	Shares	Defined	2024-05-14
2022-12-31	$350,759	27,339	+6.1%	Shares	Defined	2024-05-14
2022-09-30	$364,214	25,776	-41.0%	Shares	Defined	2024-05-14
2022-06-30	$537,915	43,662	-26.7%	Shares	Defined	2024-05-14
2022-03-31	$1,010,512	59,547	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.